Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Tenax Therapeutics (TENX) Non Operating Income (2016 - 2017)

Tenax Therapeutics' Non Operating Income history spans 8 years, with the latest figure at $693942.0 for Q4 2017.

  • For Q4 2017, Non Operating Income fell 49.17% year-over-year to $693942.0; the TTM value through Dec 2017 reached $366216.0, down 80.79%, while the annual FY2025 figure was -$33000.0, 3400.0% down from the prior year.
  • Non Operating Income for Q4 2017 was $693942.0 at Tenax Therapeutics, up from -$76226.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $1.4 million in Q4 2016 and bottomed at -$1.9 million in Q2 2014.
  • The 5-year median for Non Operating Income is $323.0 (2013), against an average of $147370.5.
  • The largest annual shift saw Non Operating Income skyrocketed 166.51% in 2015 before it tumbled 164.98% in 2017.
  • A 5-year view of Non Operating Income shows it stood at $323.0 in 2013, then plummeted by 602204.02% to -$1.9 million in 2014, then surged by 166.51% to $1.3 million in 2015, then rose by 5.56% to $1.4 million in 2016, then plummeted by 49.17% to $693942.0 in 2017.
  • Per Business Quant, the three most recent readings for TENX's Non Operating Income are $693942.0 (Q4 2017), -$76226.0 (Q3 2017), and -$28199.0 (Q2 2017).